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Gene therapy is applied into cardiovascular diseases, cancer
and diseases that are due to genomic causes.Viral vectors are
efficient carriers of genes for transduction, but some prob-
lems have become evident. Delivery vectors that are highly
potent in terms of gene transduction efficiency should also be
safe and easy to apply. Non-viral vectors have recently re-
ceived focus as gene carriers, but their transduction efficiency
is very low and not suitable for in vivo gene delivery. In addi-
tion, it is important to develop tissue-specific or selective gene
delivery system to avoid side effects in gene therapy. However,
the gene delivery system which can easily change a transfec-
tion site has not been developed. Gene delivery with ultrasound
is expected to be an attractive method for controlling gene de-
livery site due to induced driving force of gene transfection at
the limited area where it is insonated. In this study, we as-
sessed the feasibility of tissue selective gene delivery with
nanobubbles and ultrasound exposure.
Gene delivery into liver or brain – Luciferase coded plasmid
DNA (pCMV-Luc) (100 μg) and nanobubbles (500 μg) suspen-
sion was injected into the tail vein of mice. Then, US was
transdermally exposed to liver (frequency: 1 MHz, 1 W/cm2,
1 min) or transcranially exposed to brain (frequency: 1 MHz,
1.2 W/cm2, 1 min). After 1 day of injection, the luciferase ex-
pressions were measured. When ultrasound was exposed to
liver, luciferase expression in the liver was higher than that
in other tissues (Fig. 1). On the other hand, when ultrasound
was exposed to brain, luciferase expression was observed in
the brain. From these results, it was suggested that the tissue
of gene delivery was controllable by changing the site of ul-
trasound exposure.
In addition, we confirmed the gene expression cells in gene
delivery for liver. In this case, gene expression was observed in
parenchymal cells.Moreover,we also confirmed the parts of gene
expression in the brain after gene delivery. Gene expression was
observed at wide area in the brain. From these results, it is
guessed that plasmid DNAmight be extravasatedwith jet stream
induced by cavitation of nanobubbles and delivered into pa-
renchymal cells in the liver and brain.Therefore, the combination
of nanobubbles and ultrasound exposure would be a non-
invasive and tissue selective gene delivery system.
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Fig. 1 – Luciferase expression with nanobubble and
ultrasound exposure for liver.
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